Patient-Centric Clinical Trials
Table of Contents
Introduction
Patient-centric clinical trials (PCCTs) place the needs, preferences, and experiences of participants at the core of the research process. By leveraging digital tools, decentralized trial designs, and patient engagement strategies, these trials aim to improve patient recruitment, retention, and overall trial success.
Definitions and Concepts
- Decentralized Clinical Trials (DCTs): Trials that utilize telemedicine, mobile technologies, and home-based interventions to reduce patient burden.
- eConsent: Electronic consent forms that streamline patient onboarding and informed consent processes.
- Real-World Data (RWD): Data collected outside of traditional clinical trial settings, such as from wearables and patient-reported outcomes.
- Patient Engagement: Strategies designed to actively involve patients in trial design, execution, and follow-up.
Importance
Traditional clinical trials often struggle with low patient enrollment, high dropout rates, and logistical burdens. Patient-centric approaches address these challenges by enhancing patient experience, increasing diversity, and enabling more accurate, real-world insights. The evolving regulatory environment also encourages patient-centricity to improve trial efficiency and effectiveness.
Principles or Methods
- Inclusivity and Accessibility: Designing trials that accommodate diverse populations, including geographically remote patients.
- Use of Digital Health Technologies: Wearable sensors, smartphone apps, and remote monitoring enable real-time data collection.
- Minimization of Patient Burden: Flexible scheduling, home-based visits, and simplified procedures enhance patient convenience.
- Two-Way Communication: Continuous feedback loops between participants and trial investigators improve engagement and adherence.
- Regulatory and Ethical Considerations: Ensuring compliance with global regulatory guidelines (e.g., FDA, EMA) while maintaining ethical trial standards.
Application
- Oncology Trials: Personalized cancer treatment research benefits from real-time monitoring and patient feedback.
- Rare Disease Research: Engages patients globally, overcoming geographic and logistical barriers.
- Chronic Disease Management: Continuous patient monitoring through wearables supports long-term outcome tracking.
- COVID-19 and Infectious Diseases: Rapid deployment of decentralized clinical trials helps speed up vaccine and treatment development.